Category: Antimicrobial Stewardship

National Healthcare Safety Network (NHSN)Patient Safety Analysis Resource

Centers for Disease Control and Prevention

The NHSN application provides various options that allow NHSN users to analyze their surveillance data. The resources listed on the link above are intended to help you use the analysis tool, and interpret data analyzed from the Patient Safety Component of NHSN.

Implementing Antimicrobial Stewardship and C.difficile Prevention Toolkit

The Hospital and Healthsystem Association of Pennsylvania
Quality Initiatives Department Health Care Associated
Infection Prevention Managers.

Antibiotics represent the greatest risk factor for the development of CDI. While appropriate for treatment of many infectious diseases, antibiotics are often overused and misused. Antibiotics disturb normal bowel flora and place the patient at risk of acquiring Clostridioides difficile colonization and/or infection. Antibiotic Stewardship Programs (ASP) have been shown to be an integral part of a CDI reduction program.

The purpose of this toolkit is help facilities incorporate evidence-based research into their practices and measure their effectiveness. Process and outcome measures will be collected and trended.

Assessment of the Appropriateness of Antimicrobial Use in US Hospitals

Journal of the American Medical Association (JAMA) & Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia

Importance Hospital antimicrobial consumption data are widely available; however, large-scale assessments of the quality of antimicrobial use in US hospitals are limited.

Objective  To evaluate the appropriateness of antimicrobial use for hospitalized patients treated for community-acquired pneumonia (CAP) or urinary tract infection (UTI) present at admission or for patients who had received fluoroquinolone or intravenous vancomycin treatment.

Conclusions and Relevance The findings suggest that standardized assessments of hospital antimicrobial prescribing quality can be used to estimate the appropriateness of antimicrobial use in large groups of hospitals. These assessments, performed over time, may inform evaluations of the effects of antimicrobial stewardship initiatives nationally.

Implementation of Antibiotic Stewardship Activities in Critical Access Hospitals – YouTube Video

CDC and HRSA’s Federal Office of Rural Health Policy

During this webinar, leading experts will discuss the implementation of antibiotic stewardship activities to measure and improve how antibiotics are used. The discussion will emphasize the uptake of hospital core elements in the U.S., and address overcoming barriers and practical suggestions for enhancing antibiotic stewardship activities in critical access hospitals. This webinar will be co-hosted by CDC and HRSA’s Federal Office of Rural Health Policy.

2021 NHSN Training videos

Centers for Disease Control (CDC), National Healthcare Safety Network (NHSN)

NHSN subject matter experts have created training videos for 2021 NHSN updates. Recorded presentations cover the following topics:

  • LabID Analysis in Acute Care Hospitals – FAQs and Troubleshooting
  • MRSA Bacteremia and CDI LabID Event Reporting – Refresher
  • Clarifications to 2021 Bloodstream Infection Definitions
  • 2021 Secondary BSI and Chapter 17 Updates
  • Catheter-associated Urinary Tract Infection (CAUTI) – Update
  • Ventilator-associated Event (VAE) and Pediatric Ventilator-associated Event (PedVAE) Analysis
  • Surgical Site Infection (SSI) – Updates and Refresher
  • Optimizing the Group User Analysis Experience
  • NHSN Antimicrobial Resistance (AR) Option: Facility-Wide Antibiogram Report
  • Internal Data Validation
  • Healthcare Personnel Vaccination Module: Influenza Vaccination Summary Reporting for IRF Units in LTACHs and IPFs

2023 National Healthcare Safety Network (NHSN); Patient Safety Component Manual

CDC, National Healthcare Safety Network (NHSN)

The Patient Safety Component includes five modules that focus on events associated with medical devices, surgical procedures, antimicrobial agents used during healthcare, multidrug resistant organisms, and Coronavirus Infectious Disease 2019 (COVID-19).

National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination

Office of Disease Prevention and Health Promotion (ODPHP)

In recognition of health care-associated infections (HAIs) as an important public health and patient safety issue, the U.S. Department of Health and Human Services (HHS) convened the Federal Steering Committee for the Prevention of Health Care-Associated Infections (originally called the HHS Steering Committee, but was changed to reflect the addition of agencies outside of HHS). The Steering Committee’s charge is to coordinate and maximize the efficiency of prevention efforts across the federal government. Members of the Steering Committee include clinicians, scientists, and public health leaders representing:

National Action Plans

Agency for Healthcare Research and Quality (AHRQ)

National Action Plans are developed with expert input to provide a framework for collaboration among Government and non-Government entities toward large goals that have significant impact on the Nation’s health.

  • Road Map to Elimination (HAI Action Plan) provides a road map for preventing HAIs in acute care hospitals, ambulatory surgical centers, end-stage renal disease facilities, and long-term care facilities.
  • National Action Plan for Adverse Drug Events identifies the Federal Government’s highest priority strategies and opportunities for advancement and seeks to engage stakeholders in a coordinated, aligned, multisector, and health-literate effort to reduce the ADEs that are most common, clinically significant, preventable, and measurable.
  • National Action Plan on Combating Antibiotic Resistant Bacteria provides a roadmap to guide the Nation in rising to the challenge of antibiotic resistance. It outlines steps for implementing the National Strategy for Combating Antibiotic-Resistant Bacteria and addressing the policy recommendations of the President’s Council of Advisors on Science and Technology.

Antibiotic Resistance & Patient Safety Portal

Centers for Disease Control (CDC)

Interactive web-based application that was created to innovatively display data collected through CDC’s National Healthcare Safety Network (NHSN), the Antibiotic Resistance Laboratory Network (AR Lab Network), and other sources.  It offers enhanced data visualizations on Antibiotic Resistance, Use, and Stewardship datasets as well as Healthcare-Associated Infection (HAI) data.